Physician profile
Benjamin Lee White
NPI 1922489962
$1,764.53
in general payments reported to CMS, 2019-2025
11 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2021: $206 · 2022: $516 · 2023: $44.80 · 2024: $409 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396 · Gift: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.76 |
| Gift | $179.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $747.20 | 2021-2025 | |
| Ethicon US, LLC | $411.90 | 2019-2022 | |
| Conmed Corporation | $114.28 | 2021-2025 | Airseal, Conmed Trocars |
| Innovation Technologies INC | $114.00 | 2019 | |
| Tei Biosciences INC | $107.08 | 2019 | |
| Shire North American Group INC | $86.78 | 2019 | |
| Medical Device Business Services, INC. | $81.58 | 2024 | Stratafix |
| Baxter Healthcare | $32.38 | 2022 | |
| Innocoll Pharmaceuticals Limited | $24.53 | 2022 | |
| Novo Nordisk INC | $22.70 | 2023 | Wegovy |
| Heron Therapeutics, INC. | $22.10 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.